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ABSTRACT 
Introduction: Bacterial infection induces inflammation in human body. This process produces humoral 
and cellular immune responses. Cinnamomum burmanii grows very vast in Indonesia and contains 
cinnamaldehyde known to have an anti-inflammatory effect. Objective: To prove the effect of C. burmanii 
bark extract on CRP level, leukocyte count and differential blood count. 
Methods: A posttest-only controlled group design with 25 Wistar Rats divided into 5 groups was 
employed. The CN-G group was given the standard feed, the CP-G group was given the standard feed and 
levamisole 2.5 mg/KgBW, while the CBE-100, CBE-200, and CBE-400 groups were respectively given the 
standard feed and cinnamon bark extract 100 mg/kgBW, 200 mg/KgBW and 400 mg/KgBW. The 
treatments were conducted for 7 consecutive days. On day 8, all rats were injected with the suspense of S. 
aureus intraperitoneally. The blood was then drawn on day 9, followed with CRP level measurement 
using the ELISA method. The total leukocyte count and differential blood count were manually measured. 
Results: There is no significant difference in the value of CRP level (One Way ANOVA; p = 0.749) with 
the total counts of leukocytes (p=0.685), monocytes (p=0.769), and eosinophil (p=0.123) between groups. 
The neutrophils and lymphocytes of CBE-100 group are significantly different from the other groups. 
Conclusion: C. burmanii extract has a potential benefit as immunomodulator. 
Keywords: Cinnamomun burmanii, CRP, leukocytes, differential blood counts, Staphylococcus aureus 
 
ABSTRAK 
Latar Belakang: Proses inflamasi akibat infeksi bakteri oleh tubuh akan membangkitkan respon imun 
humoral dan seluler. Kayu manis spesies Cinnamomum burmanii merupakan spesies kayu manis yang 
banyak tumbuh di Indonesia. Salah satu kandungannya yaitu cynnamaldehyde diketahui mempunyai efek 
antiinflamasi. 
Tujuan: Membuktikan efek ekstrak kulit batang C. burmanii terhadap kadar C-Reactive Protein (CRP), 
jumlah leukosit, dan hitung jenis leukosit. 
Metode: Penelitian dengan desain post test only controlled group design menggunakan 25 ekor tikus Wistar 
jantan yang dibagi secara acak menjadi 5 kelompok. Kelompok CN-G diberi pakan standar, kelompok 
CP-G diberi pakan standard dan levamisole 2,5 mg/kgBB, kelompok CBE-100, CBE-200, CBE-400 diberi 
pakan standard dan ekstrak kayu manis berturut-turut sebanyak 100 mg/kgBB, 200 mg/kgBB, dan 400 
mg/kgBB. Perlakuan diberikan selama 7 hari dan pada hari ke-8 tikus diinjeksi suspensi S. aureus secara 
intraperitoneal. Pengambilan sampel darah dilakukan pada hari ke-9. Pemeriksaan kadar CRP dilakukan 
dengan metode ELISA, jumlah dan hitung jenis leukosit dihitung secara manual. 
Hasil: Hasil uji One Way ANOVA menunjukkan tidak ada beda bermakna kadar CRP (p=0,749), jumlah 
leukosit (p=0,685), hitung jenis monosit (p=0,769) dan hitung jenis eosinophil (uji Kruskal Wallis; 
p=0,123). Pada hitung jenis netrofil dan limfosit ditemukan beda bermakna pada kelompok CBE-100 
dibandingkan kelompok lainnya (p< 0,00) 
Kesimpulan: Ekstrak kulit batang kayu manis C. Burmanii mempunyai potensi sebagai 
immunomodulator.  
Kata Kunci: Cinnamomum burmanii, CRP, jumlah leukosit, hitung jenis leukosit, Staphylococcus aureus 
 
  
INTRODUCTION 
Staphylococcus aureus (S. aureus) is commensal bacteria which may be found in 30% of human 
population. Simultaneously, S. aureus is human’s main pathogen which causes infection in various organs, 
such as bacteremia, infective endocarditis, osteoarticular infection, skin and soft tissue, respiratory tract, 
and infection in users of invasive devices (Tong et al., 2015). Emerging strain which is resistant to 
antibiotic such as Methicillin-Resistant S. aureus (MRSA) makes it difficult to eradicate infectious diseases 
in Indonesia. 
Bacterial infection in the body will be initiated with an inflammatory mechanism. Inflammation is 
a biological response to a tissue injury. Inflammatory process increases the permeability of blood vessel 
wall, which is followed with immune cell migration and increased activity of signaling proteins and 
enzymes (Liao et al., 2012). Tissue macrophages, monocytes, mastocytes, platelet and endothelial cells 
may produce proinflammatory cytokines as a response to inflammation. Interleukin-1 (IL 1), interleukin 6 
(IL 6) and Tumor Necrosis Factor (TNF) alpha are cytokines released by macrophages and initiate an 
acute phase immune response. In this acute phase immune reaction, liver synthesizes a protein called C-
Reactive Protein (CRP). CRP is an acute phase protein of which value may increase 1000 times at the site 
of inflammation or infection. CRP has long been used as a laboratory sign of infection (Kingsley and 
Jones, 2008; Sproston and Ashworth, 2018). CRP is capable of recognizing self-molecule and foreign 
molecule based on pattern recognition. The bond between CRP and phosphocholine on bacterial cell 
membrane will activate complement through the classical pathway (Sproston and Ashworth, 2018).  
Cellular immune response is mediated by T lymphocyte (T cell). CD4+ plays an important role in 
cellular and humoral immune system. Naïve T cell will recognize antigen and be active in peripheral 
lymphoid organs which will be differentiated to effector T cells and memory cells. With this activation, it 
will form sufficient antibody response which will in turn activate neutrophil and macrophage, which are 
useful in defense against S. aureus infection (Yu et al., 2018). Blood cell type count illustrates the relative 
percentage of respective type of white blood cells. 
Cinnamon (Cinnamomum sp.) is of the Lauraceae family covering 54 species. The most important 
Cinnamomum species are C. burmanii, C. zeylanicum and C. cassia. C. burmanii (Java cinnamon) is an 
indiginous species to Indonesia, vastly cultivated and an important commodity in trade. Its dry bark has 
long been used as food spice and coloring (P. Chen et al., 2014). Ranasinghe, et al. (2013) presents a 
comprehensive review of cinnamon’s medical benefit, such as anti-bacteria and anti-parasite, reducing 
blood sugar and cholesterol, antioxidant, anti-nociception, anti-inflammation and so on (Ranasinghe et al., 
2013). 
The main components of C. burmanii bark essential oil are trans-cynanmaldehyde (60.72%), 
eugenol (17,62%) and coumarin (13,39%) (Faishal et al., 2017). Cynnamaldehyde is a component with 
antibacterial and anti-inflammatory effect as its main role (Liao et al., 2012). In vitro, cynnamaldehyde 
inhibits monocyte adhesion and inhibits IL-1 and TNF- secretion stimulated by lipopolysaccharide 
(LPS) as well as suppresses NF-KB expression with Helicobacter pylori infected rats (Chao et al., 2008; 
Liao et al., 2008; Muhammad et al., 2015). The effect of cinnamon extract on S. aureus infected Wistar 
rat’s immune system is not clearly known, thus this research is expected to give new information of the 
benefit of cinnamon for inflammatory process.  
  
 
METHODS 
This experimental research employs a posttest-only control group design. The research subjects 
were 25 male Wistar rats which are randomly divided into 5 groups. The groups were CN-G group given 
with the standard feed, CP-G group given with standard feed and levamisole 2.5 mg/kgBW, CBE-100 
group given with standard feed and cinnamon extract 100 mg/kgBW, CBE-200 group given with standard 
feed and cinnamon extract 200 mg/kgBW and CBE-400 group given with standard feed and cinnamon 
extract 400 mg/kgBW. The treatments were performed for 7 consecutive days and on day 8 the rats were 
injected with S. aureus suspension intraperitoneally. The blood was sampled 2 mL on day 9 through the 
rats’ lateral tail vein for CRP level examination. This research was conducted upon approval from the 
Health Research Ethics Commission (KEPK) of the Faculty of Medicine of Diponegoro University/RSUP 
Dr. Kariadi Semarang under number: 922/EC/FK-RSDK/IX/2016 issued on September 19, 2016. 
 
C. burmannii bark extraction 
C. burmanii bark was extracted using the sokletation extraction method with ethanol 70% as solvent. The 
final result of extract was obtained in the form of powder. 
 
Staphylococcus aureus injection 
S. aureus was cultured in blood agar media, then 1-2 colonies were taken for suspension into 2 mL NaCl 
0.9% until turbidity pursuant to the standard 0.5 Mac Farland. The suspension was then injected into the 
rats intraperitoneally at a concentration of 108 for 0.2 mL. 
 
CRP level examination 
CRP level was examined using the ELISA method at a wavelength of 450 nm at the GAKI Laboratory, 
Faculty of Medicine, Diponegoro University, Semarang. 
 
Leukocyte count and Leukocyte type count 
Leukocyte count and leukocyte type count were examined manually on blood sample using Neubauer 
Hemocytometer counting chamber by two examiners. Blood sample was dissolved in Turk’s solution and 
counted per 4 large fields of view. A kappa test was conducted to reduce subjectivity bias, resulting in 
p>0.8. Blood film was used to determine the type of leukocyte and colored using Hematoxylin-Eosin 
staining. 
 
Data analysis 
The data were presented in mean and standard deviation (SD). The data resulted were tested for data 
normality and homogeneity. The data of CRP level, leukocyte count, and lymphocyte and monocyte type 
count are normally distributed with homogenous variance, a one way ANOVA was then conducted with a 
post hoc test. The data of neutrophil and eosinophil type counts are not normally distributed, a Kruskal-
Wallis non-parametric test was then conducted, followed with a Mann-Whitney test. The result was 
deemed significant if p value< 0.05. 
  
 
RESULTS 
After C. burmanii extract treatment and injection with S. aureus, the mean of CRP level, leukocyte 
count and leukocyte type count were displayed in Table 1. 
 
Table 1. Mean of CRP Level, Leukocyte Count and Leukocyte Type Count  
Variable 
CN-G 
N=5 
Mean  SD 
CP-G 
N=5 
Mean  SD 
CBE-100 
N=5 
Mean  SD 
CBE-200 
N=5 
Mean  SD 
CBE-400 
N=5 
Mean  SD 
P value  
CRP Level (mg/dL) 0.81  0.45 0.840.36 0.700.15 1.000.53 0.770.38 
>0.05* 
0.09** 
0.75***  
Number of leukocyte 
() 
11203  
2376.50 
13410 
3207.10 
13460 
8060.66 
9070 
6267.73 
11798 
5007.19 
>0.05* 
0.08** 
0.69***  
Neutrophil 18.40 ± 7.33 22.20 ± 2.86 33.60 ± 9.32 19.40 ± 2.60 18.20 ± 3.11 
>0.05* 
0.11** 
0.01” 
Lymphocyte 
 
71.60 ± 3.36 70 ± 4.42 59 ± 6.89 74.20 ± 4.44 74.20 ± 3.49 
0.00* 
>0.05** 
0.21*** 
Monocyte 
 
7.40±2.30 6±1.58 5.40±3.65 6.60±2.30 7±2.92 
>0.05* 
0.26** 
0.08*** 
Eosinophil 
 
2.60 ± 2.07 1.80 ± 1.10 2 ± 0.71 1.40 ± 1.52 0.40 ± 0.55 
>0.05* 
0.08*** 
0.12” 
Note: *Saphiro Wilk; ** Levene; ***Anova;  “ Kruskall Wallis 
CN-G: Control Negative-Group; CP-G: Control Positive-Group; CBE-100: group administered with 100 mg/kgBB 
Cinnamomum burmanii; CBE-200: group administered with 200 mg/kgBB Cinnamomum burmanii CBE-400: 
group administered with 400 mg/kgBB Cinnamomum burmani 
 
Table 1 shows that statistically, the CRP level, leukocyte count, monocyte count and eosinophil 
type count are not significantly different between the treated groups (p>0.05). Meanwhile, the neutrophil 
and lymphocyte counts show significant difference between the groups (p<0.05). To identify which groups 
are significantly different, an LSD post hoc test was conducted for lymphocyte type count data and a 
Mann Whitney test was conducted for neutrophil type count data. 
 
Neutrophil type count  
The neutrophil type count of CBE-100 groups is of the highest value. Statistically, using the Mann 
Whitney test, the lymphocyte type count of CBE-100 group is significantly different from that of CN-G 
group (p=0.01) and of CBE-200 group (p=0.02) (figure 1).  
 
Lymphocyte type count 
 The mean lymphocyte type count of CBE-100 group in Table 1 seems to be of the lowest value 
among the groups. Statistically, according to the data of LSD post hoc test, the lymphocyte type count of 
CBE-100 group is significantly different from that of CNG, CPG, CBE-200 and CBE-400 groups (p<0.00) 
(figure 1). 
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Figure 1. Leucocyte count in each grou . Mann Withney 
Analysis: * p<0.05; ns not significant 
  
DISCUSSION 
Immune system is a very complex defense mechanism requiring cooperation between immune 
system, nervous system and endocrine. Its main function is to protect the body from external biological 
invasion and to regulate body’s internal environment. The imunomodulatory concept shows the non-
specific work of a substance on the immune system (cellular or effector molecule production by activated 
cells) (Balekar et al., 2014). 
Imunomodulator works in various elements of the immune system through various mechanisms. 
In this research, we find that CBE administration does not significantly influence humoral immune system 
(CRP), but indirectly influences the composition of cellular immune system (neutrophil and lymphocyte 
type counts) in pathogen infection (S. aureus injection).  
C-Reactive Protein (CRP) is an acute phase protein which significantly increases in an 
inflammatory process. In the statistical analysis, we find that there is no significant difference in the CRP 
level between the research groups, but the CRP level of CBE-100 and CBE-400 groups is generally lower 
than that of CNG group, proving that CBE influences the CRP level decrease. The meta analysis study 
conducted by Vallianou et al. shows that administration of C. burmanii extract and its derivatives may 
decrease CRP level (Vallianou et al., 2019). 
CRP is excreted in 4-6 hours after stimulus, and will be multiplied every 8 hours thereafter and 
reach its peak level in 36-50 hours. As an inflammatory sign, CRP plays a role in non-specific immunity 
which may with assistance of Ca2+ bind various molecules, such as phosphorylcoline expressed on 
damaged cell surface and polysaccharides and peptosaccharides on bacteria, parasite and fungi. 
Cynnamaldehide in C. burmanii extract may inhibit IL-1 and TNF secretion in lipopolysaccharide 
(LPS), which influences CRP expression. This secretion inhibition is mediated by modulation via JNK 
pathway, p38, activation of ERK1/2 and I-B(Chao et al., 2008; Mendes et al., 2016).  
The administration of C. burmanii bark extract in this research does not influence total leukocyte 
count and monocyte and eosinophil type counts. There is significant different in neutrophil and 
lymphocyte type counts between CBE-100 group and other groups. Neutrophil is one type of leukocyte 
serving in innate immune system, particularly in phagocyte function. Lymphocyte is a subtype of 
leukocyte serving in adaptive immune system. Immune system modulation resulting from C. burmanii bark 
extract administration influences immune response at the time of exposure to S. aureus infection (Nassan et 
al., 2015). 
T cell is an important immune cell in adaptive immune system in improvement if phagocytosis 
mechanism and will through memory process provide long-term immunity. When Naïve T cells meet an 
antigen, they will become an active lymphoblast which will be proliferated and differentiated to be effector 
cells, which directly kill pathogen or secrete cytokines, such as IFN-, IL-2 and IL-4. IL-2 improves the 
lymphocyte resistance and growth factor, while IL-4 induces antibody production. Cytokine modulation in 
administration of C. burmanii and its derivative products may influence leukocyte count and leukocyte type 
count (Lee et al., 2011). The research conducted by Roth-Walter et al. in 2014 states that cinnamaldehyde 
at low concentration increases NF-B and at high concentration shows otherwise. The anti-inflammatory 
effect of cinnamaldehyde which is mediated by NF-B blockage inhibits cell viability and influences 
proliferation and apoptosis induction in immune cells (Roth-Walter et al., 2014). 
  
This change in leukocyte population is associated with administration of C. burmanii bark extract 
which is induced by TNF- through adhesion molecule expression (Liao et al., 2012). The research 
conducted by Mendes et al. in 2016 states that cinnamaldehyde, an important constituent in C. burmanii, 
activates Transient Receptor Potential Ankyrin 1 (TPRA1) to modulate leukocyte cells (Mendes et al., 
2016). Besides influencing migration, C. burmanii extract may influence secretion of some cytokines 
serving in proliferation and leukocyte differentiation, such as Il-2 and Il-4 (Lee et al., 2011). Chen et al. in 
2014 states that procyanidin oligomer content in C. burmanii has the effect of suppressing splenocyte 
proliferation and also reducing interferon  (IFN ) and IL-2 contents (L. Chen et al., 2014).  
The interesting fact regarding C. burmanii extract is that immunomodulatory function is 
determined by its dose and species (Vetal et al., 2013). The difference in the content of different types of 
constituent causes C. burmanii bark extract to be immunostimulant and immunosuppressant (Balekar et al., 
2014). This is apparent from the result of variable of the three treatment groups administered with C. 
burmanii bark extract. In this result, we use C. burmanii extract and ethanol 70% as solvent. Ethanol 70% or 
96% renders maximum effect on cinnamaldehyde and trans-cinnamaldehyde contents. Different extraction 
method and solvent type choice influence the final content of active agent obtained during extraction 
process (Wardatun et al., 2017).  
 
CONCLUSION  
Cinnamon (C. burmanii) bark extract is a potential immunomodulator. Therefore, more extensive 
further research is needed to examine the main effect of Cinnamon (C. burmanii) bark extract on immune 
system, particularly in the process of expression of genes and cytokines which play a role in cellular 
immune system proliferation process.  
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